Skip Navigation

European Heart Journal 2004 25(15):1284-1286; doi:10.1016/j.ehj.2004.06.005
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Larsen, A. I.
Right arrow Articles by Dickstein, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsen, A. I.
Right arrow Articles by Dickstein, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Current opinion

BNP in acute coronary syndromes: the heart expresses its suffering

Alf Inge Larsen* and Kenneth Dickstein

Cardiology Division, University of Bergen, Central Hospital in Rogaland, Stavanger, Norway

* Correspondence to: Dr. Alfe Inge Larsen, MD, Cardiology Division, University of Bergen, Central Hospital in Rogaland, P.O. Box 8100, 4001 Stavanger, Norway. Tel.: +47-51-518000; fax: +41-51-519905
E-mail address: alfil@broadpark.no

The first 10% of the full text of this article appears below.

The use of N-BNP is well established in the diagnosis and staging of patients with heart failure1 and its ability to predict prognosis in this population has been verified in several frequently cited studies.2 Recently, measurement of N-BNP has also been shown to be a useful prognostic tool in the population of patients with ACS.3 In a past issue of this journal, Bazzino et al., further extended our knowledge in that they demonstrated the prognostic value of elevated levels of N-terminal B-type natriuretic peptide (N-BNP) in addition to standardised risk-stratification schemes in patients that were included consecutively with acute coronary syndromes (ACS).4

Risk stratification of patients with ACS

Although, early treatment with fibrinolytic agents or percutaneous coronary intervention is well documented in acute ST-elevation myocardial infarction (STEMI), the optimal treatment strategy for . . . [Full Text of this Article]

Identifying patients with ACS at risk of developing subsequent acute heart failure

Clinical implications?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
R. V. Jeger, A. M. Lowe, C. E. Buller, M. E. Pfisterer, V. Dzavik, J. G. Webb, J. S. Hochman, U. P. Jorde, and for the SHOCK Investigators
Hemodynamic Parameters Are Prognostically Important in Cardiogenic Shock But Similar Following Early Revascularization or Initial Medical Stabilization: A Report From the SHOCK Trial
Chest, December 1, 2007; 132(6): 1794 - 1803.
[Abstract] [Full Text] [PDF]